Division of Dermatology

Dermatopharmacology Fellowship

Program Leadership

Director: Holly Kanavy, MD


The Fellowship Experience

The Albert Einstein/Montefiore Dermatology Clinical Research Fellowship Program provides an in-depth experience in the clinical research related to dermatology.The program offers clinical research experience tailored to each fellow’s needs. Working with academic clinicians, fellows gain clinical skills that serve them and their patients in the future.  

Fellowship Goals

  • To develop skills in the planning, implementation and conduct of clinical trials
  • To develop skills in the evaluation, management and prevention of dermatologic diseases, and data analysis
  • To gain experience with these diseases in the clinical research (practice) setting
  • To develop effective interpersonal and communication skills with study patients, their families, members of the research staff, and pharmaceutical sponsors in the clinical research setting
  • To become familiar with regulations at the federal and state level that govern current approaches and tools for conducting clinical trials
  • To develop an understanding of the drug development process, and good clinical practices


Prior Research Studies and Clinical Trials

  • 10-Year, Post-marketing, Observational, Registry to Assess Long Term Safety of HUMIRA® 
  • (Adalimumab) in Adult Patients with Chronic Plaque Psoriasis (Ps)
  • A Multicenter Study with a Randomized, Double-Blind, Placebo-Controlled Induction Dosing 
  • Period Followed by a Randomized Maintenance Dosing Period and a Long-Term Extension Period to Evaluate the Efficacy a Safety of LY2439821 in Patients with Moderate-to-Severe Plaque Psoriasis
  • A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
  • A Phase 3 Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa PIONEER (OPEN-LABEL EXTENSION)
  • A Phase 3b, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate a “Subject-tailored” Maintenance Dosing Approach in Subjects with Moderate-to-Severe Plaque Psoriasis
  • An Observational, Multicenter Disease Registry to Evaluate Clinical Practice Trends and Outcomes in Adult Patients with Hidradenitis Suppurativa – UNITE
  • A Multicenter, Randomized, Double-blind, Parallel group, Vehicle-controlled study of the Safety 
  • and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 years of age) with Mild-to-Moderate Plaque Psoriasis
  • A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
  • A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients with Pyoderma Gangrenosum
  • A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed with Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated with Valchlor®
  • An Open-label Phase II Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients with Persistent, Moderate-to-Severe Atopic Dermatitis
  • Impact of Hidradenitis Suppurativa on Quality of Life Functions: A Cross-Sectional Analysis of 400 Patients
  • Development and Maintenance of a National Registry for Patients with Hidradenitis Suppurativa
  • Randomized Pilot Study Investigating the Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum



Holly Kanavy, DO
Phone: (718) 920-2680


Click here to log in